Cutera, Inc. (NASDAQ:CUTR) CFO Ronald J. Santilli sold 12,000 shares of the stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $34.00, for a total transaction of $408,000.00. Following the sale, the chief financial officer now directly owns 75,253 shares of the company’s stock, valued at approximately $2,558,602. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Cutera, Inc. (CUTR) remained flat at $33.75 during mid-day trading on Friday. 76,640 shares of the company’s stock were exchanged. The firm has a market cap of $472.67 million, a P/E ratio of 72.58 and a beta of 0.60. The stock has a 50-day moving average of $28.32 and a 200-day moving average of $22.96. Cutera, Inc. has a 12 month low of $10.54 and a 12 month high of $34.91.

Cutera (NASDAQ:CUTR) last posted its earnings results on Monday, August 7th. The medical device company reported $0.13 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.03 by $0.10. Cutera had a net margin of 5.07% and a return on equity of 11.64%. The firm had revenue of $36.40 million during the quarter, compared to analyst estimates of $32.08 million. During the same quarter in the prior year, the business posted $0.07 EPS. The business’s revenue was up 32.4% compared to the same quarter last year. On average, equities analysts anticipate that Cutera, Inc. will post $0.52 EPS for the current fiscal year.

Cutera announced that its board has initiated a stock buyback program on Monday, August 7th that permits the company to repurchase $25.00 million in shares. This repurchase authorization permits the medical device company to buy up to 6.8% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

COPYRIGHT VIOLATION WARNING: “Cutera, Inc. (CUTR) CFO Sells $408,000.00 in Stock” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/08/18/cutera-inc-cutr-cfo-sells-408000-00-in-stock.html.

A number of research analysts recently weighed in on CUTR shares. BidaskClub raised shares of Cutera from a “hold” rating to a “buy” rating in a research report on Saturday, August 12th. Gabelli reaffirmed a “buy” rating on shares of Cutera in a research report on Wednesday, August 9th. Maxim Group reaffirmed a “buy” rating and issued a $33.00 target price (up previously from $27.00) on shares of Cutera in a research report on Thursday, July 13th. Roth Capital raised their target price on shares of Cutera from $32.00 to $39.00 and gave the company a “buy” rating in a research report on Tuesday, August 8th. Finally, Sidoti reaffirmed a “buy” rating and issued a $32.00 target price (up previously from $30.00) on shares of Cutera in a research report on Friday, July 7th. Six investment analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and an average price target of $33.25.

Several hedge funds have recently bought and sold shares of the company. California State Teachers Retirement System raised its stake in Cutera by 1.3% in the second quarter. California State Teachers Retirement System now owns 23,405 shares of the medical device company’s stock valued at $606,000 after buying an additional 300 shares during the last quarter. American International Group Inc. raised its position in Cutera by 7.0% in the first quarter. American International Group Inc. now owns 7,221 shares of the medical device company’s stock valued at $149,000 after buying an additional 475 shares during the last quarter. Bank of America Corp DE raised its position in Cutera by 0.4% in the first quarter. Bank of America Corp DE now owns 139,087 shares of the medical device company’s stock valued at $2,879,000 after buying an additional 500 shares during the last quarter. Nationwide Fund Advisors raised its position in Cutera by 8.4% in the second quarter. Nationwide Fund Advisors now owns 7,216 shares of the medical device company’s stock valued at $187,000 after buying an additional 561 shares during the last quarter. Finally, The Manufacturers Life Insurance Company raised its position in Cutera by 12.0% in the second quarter. The Manufacturers Life Insurance Company now owns 11,479 shares of the medical device company’s stock valued at $297,000 after buying an additional 1,230 shares during the last quarter. Hedge funds and other institutional investors own 84.44% of the company’s stock.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.